Abstract
Persistent pulmonary hypertension of the neonate (PPHN) characteristically is seen in full-term or postterm infants. Occasionally, PPHN complicates the course of hyaline membrane disease in preterm infants. This report documents the unusual occurrence of PPHN in a preterm very low birthweight infant without apparent pulmonary parenchymal disease.
MeSH terms
-
Alprostadil
-
Dopamine / therapeutic use
-
Female
-
Humans
-
Infant, Low Birth Weight*
-
Infant, Newborn
-
Infant, Premature, Diseases / diagnosis*
-
Infant, Premature, Diseases / etiology
-
Infant, Premature, Diseases / therapy
-
Oxygen Inhalation Therapy
-
Persistent Fetal Circulation Syndrome / diagnosis*
-
Persistent Fetal Circulation Syndrome / etiology
-
Persistent Fetal Circulation Syndrome / therapy
-
Prostaglandins E / therapeutic use
-
Tolazoline / therapeutic use
-
Vasodilator Agents / therapeutic use
Substances
-
Prostaglandins E
-
Vasodilator Agents
-
Tolazoline
-
Alprostadil
-
Dopamine